Advanced Biomed Inc. Common Stock (ADVB) financial statements and ratios from SEC XBRL: revenue $0.0B (TTM), net margin -13080.3%, revenue growth -40.3% YoY, P/E 3.2. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $24915.00 |
| Revenue (TTM) | $0.0B |
| Net Margin | -13080.3% |
| Operating Margin (TTM) | 23664.2% |
| Revenue Growth (YoY) | -40.3% |
| EPS Growth (YoY) | -875.0% |
| FCF Growth (YoY) | 23.6% |
| P/E Ratio | 3.2 |
| EV / EBITDA | 2.1 |
| Price / Book | 1.44 |
| Price / Sales | 327.83 |
| FCF Yield | -44.1% |
| Altman Z-Score | 39.38 (safe) |
| Industry P/E (Healthcare Services) | 24.6 |
| Sector P/E (Healthcare) | 21.6 |
ADVB overview · ADVB earnings · ADVB KPIs · ADVB documents · ADVB ownership · ADVB peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.